SUN IN SEAD
Integrates clinical data, biobank provenance, NGS ground truth, Raman spectra and ML validation into a pseudonymised, traceable research platform.
SUN IN SEAD (Super sensitive intelligent nanobiotechnology system for early disease diagnosis) is an industrial research and experimental development project, PR Calabria FESR FSE 2021–2027 – Action 1.1.1, CUP J49I24001710005, developing an integrated predictive diagnostics platform for screening and monitoring complex oncological diseases through nanotechnology, plasmonic chips and artificial intelligence. Beta 80 SpA is the lead partner. The platform separates direct patient identity from laboratory sample identity through pseudonymised identifiers, and integrates biobanks and external systems through REST, Kafka, JSON, XML, CSV and controlled file exchange, with authentication, API contracts, response codes and OpenAPI documentation.
Beta 80 SpA is the lead partner of the project. From 1 April 2026 Davide Scuteri Moretti is formally assigned to project activities concerning the Bio Data Bank and Intelligent Computing System: he coordinates testing of the Bio Data Bank, supervises development of intelligent computing software modules, oversees experimentation of the IT platform on biological samples, and manages final testing and validation activities.
- WP7 – Bio Data BankPlanning and supervision of functional, performance and security testing.
- WP8 – Intelligent Computing SystemCoordination and verification of software module development.
- WP9 – IT Platform ExperimentationSupervision of experimental activities and evaluation of the IT system on biological samples.
- WP10 – Final ValidationManagement of final testing and validation of the platform and its predictive models.
- —Provenance from patient to prediction
- —AI validation against NGS molecular ground truth
- —Traceable Raman spectrum preprocessing, feature extraction and model outputs
- Test definition
- Biological samples
- Biobank and reagent information
- NGS molecular ground truth
- Raman acquisition parameters
- Raw and extracted spectral data
- Predictions, confidence scores and concordance
- Corrective actions and validation results
Pseudonymisation, GDPR compliance, auditability across clinical, engineering and validation domains.